Genetic testing can improve the safety of warfarin therapy for patients at high risk of VTE following hip or knee replacement surgery a new study has found. The findings from the trial known as GIFT (Genetics Informatics Trial of Warfarin to Prevent Deep Venous Thrombosis), could see use of genotype-guided warfarin dosing become more widespread, according to ...
Warfarin genotyping reduces adverse events
By Sunalie Silva
28 Sep 2017